{"schema_version":"1","generated_at":"2026-11-02T18:46:37.375Z","data_as_of":null,"url":"https://www.findmykol.com/kol/lawrence-leichman","json_url":"https://www.findmykol.com/kol/lawrence-leichman/profile.json","record_kind":"basic","profile_kind":"clinical","person":{"slug":"lawrence-leichman","name":"Lawrence Leichman","credential":"MD","specialty":"Medical Oncology","specialty_raw":"Medical Oncology","therapeutic_area":"Oncology","therapeutic_areas":["Oncology"],"city":"Palm Springs","state":"CA","region":{"label":"West","url":"https://www.findmykol.com/region/west"}},"identifiers":{"npi":"1891792305"},"summary":"Lawrence Leichman is an Oncology physician. ClinicalTrials.gov lists 10 registered studies matched to this name.","overview":null,"focus":{"indications":[],"research_topics":["Oncology"]},"scholarship":{"note":"Research metrics are not shown for this record: either no confident publication match for this name, or more than one clinician shares the matched author record."},"trials":{"count":10,"shown":3,"withheld":7,"matched_by":"investigator name, confirmed against institution and geography","rows":[{"nct":"NCT01360853","title":"Gemcitabine and ON 01910.Na in Previously Untreated Metastatic Pancreatic Cancer","phase":"PHASE3","status":"COMPLETED","role":"Overall official","sponsor":"Traws Pharma, Inc.","source_url":"https://clinicaltrials.gov/study/NCT01360853","trial_url":"https://www.findmykol.com/trial/NCT01360853"},{"nct":"NCT01116271","title":"Study of Selumetinib (AZD6244)(ARRY-142886) in Combination With Irinotecan in Previously Treated Patients With Colorec","phase":"PHASE2","status":"COMPLETED","role":"Overall official","sponsor":"AstraZeneca","source_url":"https://clinicaltrials.gov/study/NCT01116271","trial_url":"https://www.findmykol.com/trial/NCT01116271"},{"nct":"NCT00912743","title":"Efficacy and Safety of Olaparib in Pretreated Patients With Measurable Colorectal Cancer, Stratified by Microsatellite Instability (MSI) Status","phase":"PHASE2","status":"COMPLETED","role":"Overall official","sponsor":"AstraZeneca","source_url":"https://clinicaltrials.gov/study/NCT00912743","trial_url":"https://www.findmykol.com/trial/NCT00912743"}],"source":"trials"},"prescribing":{"data_year":2024,"areas_total":1,"areas_shown":1,"areas":[{"area":"Cancer & immunology","share_pct":100,"classes_total":1,"classes":[{"class":"Cytochrome P450 17A1 Inhibitor","setting":"prescribed","share_pct":100,"drugs":[{"name":"Abiraterone Acetate","share_pct":100}],"max_beneficiaries":null}]}],"care_setting":{"dominant":"office","data_year":2019,"office_pct":100,"facility_pct":0},"source":"medicare"},"funding":{"award_count":1,"fiscal_years":{"first":1993,"last":1995},"rows_total":3,"shown":3,"withheld":0,"matched_by":"principal investigator name at an organization in the practice state","rows":[{"project":"R01CA056119","title":"RESPONSE DETERMINANTS IN ESOPHAGEAL AND GASTRIC CANCERS","fiscal_year":1995,"organization":"UNIVERSITY OF SOUTHERN CALIFORNIA","source_url":"https://reporter.nih.gov/quickSearch/R01CA056119"},{"project":"R01CA056119","title":"RESPONSE DETERMINANTS IN ESOPHAGEAL AND GASTRIC CANCERS","fiscal_year":1994,"organization":"UNIVERSITY OF SOUTHERN CALIFORNIA","source_url":"https://reporter.nih.gov/quickSearch/R01CA056119"},{"project":"R01CA056119","title":"RESPONSE DETERMINANTS IN EGOPHAGEAL AND GASTRIC CANCERS","fiscal_year":1993,"organization":"UNIVERSITY OF SOUTHERN CALIFORNIA","source_url":"https://reporter.nih.gov/quickSearch/R01CA056119"}],"source":"grants"},"contact":{"address_1":"1180 N INDIAN CANYON DR","address_2":"STE E218","city":"Palm Springs","state":"CA","zip":"922624885","phone":"760-416-4860","source_url":"https://npiregistry.cms.hhs.gov/provider-view/1891792305","source":"identity"},"similar":[{"name":"Carl June","slug":"carl-june","institution":"University of Pennsylvania","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/carl-june","json_url":"https://www.findmykol.com/kol/carl-june/profile.json"},{"name":"Rainer Storb","slug":"rainer-storb","institution":"University of Washington","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/rainer-storb","json_url":"https://www.findmykol.com/kol/rainer-storb/profile.json"},{"name":"Christina Fitzmaurice","slug":"christina-fitzmaurice","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/christina-fitzmaurice","json_url":"https://www.findmykol.com/kol/christina-fitzmaurice/profile.json"},{"name":"Larry Norton","slug":"larry-norton","institution":"Memorial Sloan Kettering Cancer Center","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/larry-norton","json_url":"https://www.findmykol.com/kol/larry-norton/profile.json"}],"coverage":{"note":"A basic directory record. Sections absent here were not yet checked for this person, so absence means not yet looked, never none found.","not_yet_checked":["congress","network","presence","recognition"]},"not_included":{"note":"This document is the public layer: neutral facts cited to their source. Judgments (influence tier, archetype, trajectory commentary) and the itemized rows past each section's public teaser are account features and are not served here or to crawlers.","withheld_rows":{"trials":7}},"sources":{"identity":{"name":"NPPES (CMS)","url":"https://npiregistry.cms.hhs.gov","provides":"Identity, specialty and practice location for every U.S. clinician","coverage":"Practice location (not mailing) from the NPPES record","record_last_updated":"2017-04-17","collected_at":"2026-11-02T00:00:00.000Z"},"trials":{"name":"ClinicalTrials.gov","url":"https://clinicaltrials.gov","provides":"Investigator roles on registered clinical studies"},"medicare":{"name":"CMS Medicare Part D Prescribers and Part B","url":"https://data.cms.gov/provider-summary-by-type-of-service","provides":"Share of this prescriber's Medicare fee-for-service prescribing by drug class and therapeutic area, classified with WHO ATC and NLM RxClass","disclaimer":"Proportions of the prescriber's own classified prescribing, never patient counts or dollar amounts. Fee-for-service only; CMS publishes about 17 months after the fact and suppresses counts of ten patients or fewer.","data_year":2024},"grants":{"name":"NIH RePORTER","url":"https://reporter.nih.gov","provides":"Federally funded research awards, by fiscal year"}},"methodology_url":"https://www.findmykol.com/about#methodology"}